A field of the Novavax Covid-19 vaccine organized at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022.
Bloomberg | Bloomberg | Getty Pictures
Biotechnology firm Novavax introduced on Friday that its Covid-19 vaccine has been licensed for emergency use by the U.S Meals and Drug Administration for adolescents between the ages of 12 and 17.
In July, Novavax’s two-dose Covid-19 vaccine for adults ages 18 and over acquired its emergency approval from the FDA.
Having extra vaccine…